Cargando…
Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881308/ https://www.ncbi.nlm.nih.gov/pubmed/36707787 http://dx.doi.org/10.1186/s12874-023-01850-7 |
| _version_ | 1784879084132630528 |
|---|---|
| author | Ismail, R. K. Schramel, F. M. N. H. van Dartel, M. Pasmooij, A. M. G. der Welle, C. M. Cramer-van Hilarius, D. L. de Boer, A. Wouters, M. W. J. M. van de Garde, E. M. W. |
| author_facet | Ismail, R. K. Schramel, F. M. N. H. van Dartel, M. Pasmooij, A. M. G. der Welle, C. M. Cramer-van Hilarius, D. L. de Boer, A. Wouters, M. W. J. M. van de Garde, E. M. W. |
| author_sort | Ismail, R. K. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9881308 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98813082023-01-28 Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC Ismail, R. K. Schramel, F. M. N. H. van Dartel, M. Pasmooij, A. M. G. der Welle, C. M. Cramer-van Hilarius, D. L. de Boer, A. Wouters, M. W. J. M. van de Garde, E. M. W. BMC Med Res Methodol Correction BioMed Central 2023-01-27 /pmc/articles/PMC9881308/ /pubmed/36707787 http://dx.doi.org/10.1186/s12874-023-01850-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Ismail, R. K. Schramel, F. M. N. H. van Dartel, M. Pasmooij, A. M. G. der Welle, C. M. Cramer-van Hilarius, D. L. de Boer, A. Wouters, M. W. J. M. van de Garde, E. M. W. Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC |
| title | Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC |
| title_full | Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC |
| title_fullStr | Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC |
| title_full_unstemmed | Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC |
| title_short | Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC |
| title_sort | correction: individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in nsclc |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881308/ https://www.ncbi.nlm.nih.gov/pubmed/36707787 http://dx.doi.org/10.1186/s12874-023-01850-7 |
| work_keys_str_mv | AT ismailrk correctionindividualpatientdatatoallowamoreelaboratedcomparisonoftrialresultswithrealworldoutcomesfromsecondlineimmunotherapyinnsclc AT schramelfmnh correctionindividualpatientdatatoallowamoreelaboratedcomparisonoftrialresultswithrealworldoutcomesfromsecondlineimmunotherapyinnsclc AT vandartelm correctionindividualpatientdatatoallowamoreelaboratedcomparisonoftrialresultswithrealworldoutcomesfromsecondlineimmunotherapyinnsclc AT pasmooijamg correctionindividualpatientdatatoallowamoreelaboratedcomparisonoftrialresultswithrealworldoutcomesfromsecondlineimmunotherapyinnsclc AT derwellecmcramervan correctionindividualpatientdatatoallowamoreelaboratedcomparisonoftrialresultswithrealworldoutcomesfromsecondlineimmunotherapyinnsclc AT hilariusdl correctionindividualpatientdatatoallowamoreelaboratedcomparisonoftrialresultswithrealworldoutcomesfromsecondlineimmunotherapyinnsclc AT deboera correctionindividualpatientdatatoallowamoreelaboratedcomparisonoftrialresultswithrealworldoutcomesfromsecondlineimmunotherapyinnsclc AT woutersmwjm correctionindividualpatientdatatoallowamoreelaboratedcomparisonoftrialresultswithrealworldoutcomesfromsecondlineimmunotherapyinnsclc AT vandegardeemw correctionindividualpatientdatatoallowamoreelaboratedcomparisonoftrialresultswithrealworldoutcomesfromsecondlineimmunotherapyinnsclc |